VERU INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $7.00 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2015-07-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2015-07-30
- VERU INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2014-06-30 was $7.00K.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2014-03-31 was $0.00.
- VERU INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2013-12-31 was -$214.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 9 month |
|---|---|---|---|
| 2014-06-30 | $7.00K 10-Q · filed 2015-07-30 | $7.00K derived: sum of 2 quarters · filed 2015-07-30 | -$207.00K 10-Q · filed 2015-07-30 |
| 2014-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-30 | -$214.00K 10-Q · filed 2015-04-30 | |
| 2013-12-31 | -$214.00K 10-Q · filed 2015-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |